BLS — BLS Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual balance sheet for BLS Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	R2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.066	3.85	1.03	7.67	13.3
Net Total Accounts Receivable
Net Total Receivables	0.253	0.936	1.52	3.53	7.88
Total Inventory
Total Other Current Assets
Total Current Assets	0.407	6.04	5.59	15.7	41.2
Net Property, Plant And Equipment	0.043	0.085	0.824	3.37	10.1
Net Intangible Assets
Other Long Term Assets
Total Assets	0.45	17.7	6.7	19.6	52.1
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.815	2.69	2.91	6.4	14.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.815	2.56	3.09	7.17	21
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	-0.365	15.1	3.61	12.4	31.1
Total Liabilities & Shareholders' Equity	0.45	17.7	6.7	19.6	—
Total Common Shares Outstanding